Novo Nordisk Seeks to Block Copycat Versions of Weight-Loss Drugs
The maker of weight loss drug Wegovy and diabetes treatment Ozempic is calling on the Food and Drug Administration to prevent compounding pharmacies from manufacturing their own version of the popular drugs.
The maker of weight loss drug Wegovy and diabetes treatment Ozempic is calling on the Food and Drug Administration to prevent compounding pharmacies from manufacturing their own version of the popular drugs.
What's Your Reaction?
